D. E. Shaw & Co., Inc. - CHINA BIOLOGIC PRODS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$546,000
-10.8%
4,827
-21.0%
0.00%0.0%
Q1 2017$612,000
-10.0%
6,112
-3.4%
0.00%0.0%
Q4 2016$680,000
-68.5%
6,327
-63.5%
0.00%
-75.0%
Q3 2016$2,158,000
-49.5%
17,332
-56.9%
0.00%
-42.9%
Q2 2016$4,275,000
-21.7%
40,209
-15.6%
0.01%
-30.0%
Q1 2016$5,457,000
-39.7%
47,663
-25.0%
0.01%
-23.1%
Q4 2015$9,053,000
+115.8%
63,548
+36.0%
0.01%
+85.7%
Q3 2015$4,195,000
-65.5%
46,714
-55.8%
0.01%
-61.1%
Q2 2015$12,160,000
+251.1%
105,586
+191.2%
0.02%
+260.0%
Q1 2015$3,463,000
+74.2%
36,254
+22.6%
0.01%
+66.7%
Q4 2014$1,988,000
-3.7%
29,574
-22.7%
0.00%0.0%
Q3 2014$2,064,000
+337.3%
38,254
+260.4%
0.00%
+200.0%
Q2 2014$472,00010,6140.00%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Segantii Capital Management Ltd 50,000$5,288,0005.80%
RUDMAN ERROL M 37,001$3,934,0003.76%
INDUS CAPITAL PARTNERS, LLC 349,210$37,128,0003.60%
WARBURG PINCUS LLC 1,312,200$139,513,0003.04%
SPQ Asia Capital Ltd 96,000$10,206,0002.63%
OBERWEIS ASSET MANAGEMENT INC/ 82,775$8,801,0002.62%
Ativo Capital Management LLC 94,074$10,002,0002.44%
Sensato Investors LLC 99,764$10,607,0001.72%
Cormorant Asset Management, LP 112,867$12,000,0001.70%
BARING ASSET MANAGEMENT Ltd 131,284$13,958,0001.14%
View complete list of CHINA BIOLOGIC PRODS INC shareholders